이탈리아 상처 치료 관리 시장 규모는 2025년에 5억 1,397만 달러로 추정되며, 예측 기간(2025-2030년) 동안 CAGR 5.06%로 성장하여 2030년에는 6억 5,785만 달러에 달할 것으로 예측됩니다.
이탈리아의 상처 치료 관리 시장은 고령화, 만성 질환률의 상승, 그리고 의료 기술의 진보로 인해 헬스케어 분야의 중요한 요소가 되고 있습니다. 동시장은 경쟁이 격렬하며 이탈리아 국내에는 국제적인 기업이나 현지 기업이 진출하고 있습니다.
또한 상처 관리에 원격 의료를 도입하면서 상처, 궤양 및 기타 상처 관리의 치료에 중요한 역할을 하고 있습니다. 재택에서 환자의 치료나 지도를 실시함으로 인해 중요하지 않은 여러가지 치료 상황을 관리하게 되었습니다.
만성 창상, 궤양 및 당뇨병성 궤양의 발생률 증가나 노인 인구의 부담 증가 등의 요인이 시장 성장의 원동력이 되고 있습니다.노년 인구 증가는 질병 부담 증가로 이어집니다.
상처가 치유되기까지의 시간은 여러 가지 이유로 크게 달라집니다. 인지기능의 저하 등이 그 예이며 따라서 이탈리아에서는 고령자에게 상처가 많이 생기기 때문에 상처 치료와 관리의 기회가 발생하여 예측 기간중 시장 성장이 촉진될 것으로 예상됩니다.
IDF에 따르면 2021년 이탈리아의 당뇨병 환자수는 447만 300명이었으며 2045년에는 459만 5,400명에 이를 것으로 예측되고 있습니다.
제품의 기술적 진보, 과학적 조사 연구, 그리고 시장 기업의 전략적 이니셔티브가 시장 성장을 뒷받침할 것으로 예측됩니다.
따라서 이탈리아의 상처 치료 관리 시장은 연구 활동 증가와 신기술의 가용성에 의해 확대되고 있으며, 예측 기간 중의 성장이 예상되고 있습니다.
조사 범위
욕창이란 주로 피부에 가해지는 지속적인 압력에 의해 피부나 그 아래의 조직에 생기는 창상을 말합니다.
노인 인구 증가, 만성 질환의 부담 증가, 장기 요양을 필요로 하는 중상 등의 요인이 예측 기간 동안 이탈리아 상처 치료 관리 시장의 욕창 분야의 성장을 견인할 것으로 예상됩니다.
2023년 이탈리아 인구의 약 24%는 65세 이상이었으며 2022년 이탈리아 인구 중 80세 이상은 7.6%였습니다.
상처 치료 기기에는 음압 치료를 이용한 치료기기, 감압기기, 압박 요법, 고압 산소기기 등이 포함됩니다.
예를 들어, 2023년 2월 Scientific Reports 잡지의 기사에 따르면 앉아서 생활하는 라이프 스타일, 과체중, 그리고 비만으로 이탈리아 당뇨병 유병률은 6.4%에 달했습니다.
중앙 규제 당국의 제품 승인도 시장 부문의 성장을 뒷받침하고 있습니다. STIMULAN Rapid Cure 디바이스와 STIMULAN Kit는 항생제를 뼈와 연조직으로 직접 운반할 수 있습니다.
이탈리아 상처 치료 관리 시장은 세계적 및 지역적으로 사업을 전개하는 많은 기업이 존재하기 때문에 단편화되어 있습니다. 주요 기업으로는 Braun SE, Coloplast Group, ConvaTec Inc., Integra LifeSciences, Molnlycke Health Care AB, Medtronic, Smith Nephew, Paul Hartmann AG 등이 있습니다.
The Italy Wound Care Management Market size is estimated at USD 513.97 million in 2025, and is expected to reach USD 657.85 million by 2030, at a CAGR of 5.06% during the forecast period (2025-2030).
The wound care market in Italy is a vital component of the larger healthcare landscape, propelled by an aging demographic, rising chronic disease rates, and strides in medical technology. The market is highly competitive, with several international and local players operating in Italy. As part of the European Union, Italy adheres to the EU Medical Device Regulation (MDR) that governs the approval and distribution of wound care products.
Further, the implementation of telemedicine in wound management also played an important role in the treatment of wounds, ulcers, and other facets of wound management. For instance, according to a study published in February 2023, through the implementation of telemedicine, patients with diabetes who had foot ulcers were able to receive care at home. Various non-critical situations were managed outside hospitals and clinics by providing patients care and guidance at home by visiting nurses, doctors, and telemedicine. Such initiatives led to a rise in the adoption of telemedicine services for wound management during the pandemic, and the trend continued even after the lockdowns were lifted and the situation stabilized. This is likely to drive the market growth during the forecast period.
Factors such as the increasing incidence of chronic wounds, ulcers, and diabetic ulcers and the rising burden of the geriatric population are fueling the market growth. An increasing geriatric population contributes to disease burdens. According to the Overpopulation Project, with almost a quarter of its population aged 65 years and above, Italy has become one of the countries with the largest elderly population.
The time it takes for a wound to heal varies greatly for many reasons. Multiple comorbidities and risk factors that increase wound chronicity are common among older adults. Some of these comorbidities include diabetes mellitus, cardiovascular diseases, inadequate nutrition, decreased mobility, and declining cognitive functions. Therefore, the prevalence of wounds among the elderly in Italy is expected to create wound care and management opportunities, driving market growth during the forecast period.
According to the IDF, the number of people with diabetes in Italy in 2021 was 4,470.3 thousand, and this number is expected to reach 4,595.4 thousand in 2045. This anticipated increase in the diabetic population, who are more susceptible to diabetic foot ulcers, may drive the market growth.
Technological advancements in products, scientific research studies, and market players' strategic initiatives are projected to boost market growth. For instance, in October 2021, scientists at the University of Bologna in Italy developed smart bandages equipped with sensors that can record the wounds' status. The smart bandage can read moisture levels, which is transferred to a dedicated application on a smartphone.
Therefore, Italy's wound care management market is expanding with the increase in research and the availability of new technologies and is anticipated to witness growth during the forecast period. However, reimbursement issues for advanced wound care products are expected to restrain the growth of the market.
Scope of the Report
Pressure ulcers are wounds on the skin and underlying tissue primarily caused by persistent pressure on the skin. Although they can affect anyone, they typically afflict those who are bedridden or spend a lot of time in a chair or wheelchair. Also, older adults (70 years and above) and obese people are most likely to get affected by pressure ulcers.
Factors such as the growing geriatric population, the increasing burden of chronic diseases, and serious injuries requiring long-term bed rest are expected to drive the growth of the pressure ulcer segment of the Italian wound care management market during the forecast period.
The growing burden of the geriatric population in the country is expected to contribute to the market segment's growth. For instance, according to the Eurostat database updated in June 2023, nearly 24% of the Italian population in 2023 were 65 years and above. The database also reported that in 2022, 7.6% of the Italian population was aged 80 years and above. Since older adults commonly have lower mobility and spend a lot of time sitting and resting, they are at an increased risk of pressure ulcers. With such a high geriatric population in the country, the target population for pressure ulcer care products is expected to increase, which may contribute to the growth of the segment.
Wound care devices include therapy devices based on negative pressure therapy, pressure relief devices, compression therapy, and hyperbaric oxygen equipment. Factors such as the growing burden of targeted diseases and increasing research studies in the area of wound care devices are propelling the growth of the market segment during the forecast period.
For instance, an article from Scientific Reports in February 2023 states that the prevalence of diabetes amounts to 6.4% in Italy owing to sedentary lifestyles, overweight, and obesity.
The centralized regulatory authority's approval of products also propels the market segment's growth. For instance, in April 2021, Biocomposites received the European CE mark's approval to use STIMULAN in infected bone and soft tissue. The STIMULAN Rapid Cure device and STIMULAN Kit can carry an antibiotic directly into the bone and soft tissues. Thus, owing to the above-mentioned factors, the wound care devices segment is expected to project significant growth during the forecast period.
The Italian wound care management market is fragmented due to the presence of many companies operating globally and regionally. The competitive landscape includes analyzing a few international and local companies that hold market shares and are well known. Some key players are 3M, B. Braun SE, Coloplast Group, ConvaTec Inc., Integra LifeSciences, Molnlycke Health Care AB, Medtronic, Smith + Nephew, and Paul Hartmann AG.